subgroup of
drug)
→
ReceivesAction
→
proven safe
| Typicality: | 0.538 |
| Saliency: | 0.296 |
| before hitting the market | 5 | temporal |
| new drug → be proven → safe | 5 |
| new drug → be shown to be → safe | 5 |
| negative | neutral | positive |
| 0.163 | 0.566 | 0.271 |
| Raw frequency | 10 |
| Normalized frequency | 0.296 |
| Modifier score | 1.000 |
| Perplexity | 244.259 |